Radium 223 en tiempos de COVID-19

  • Diego Barreiro Universidad de Buenos Aires, Buenos Aires, Argentina https://orcid.org/0000-0003-1074-6749
  • Danny Roberto Mena-Cortes Universidad de Buenos Aires, Buenos Aires, Argentina
Palabras clave: COVID-19, pandemic

Resumen

Contexto clínico

Para el tratamiento del cáncer de próstata resistente a la castración (CPRC) metastásico se deben utilizar tratamientos que proporcionen beneficio en sobrevida global.

Los pacientes metastásicos sensibles a castración recibirirán tratamientos hormonales de segunda generación o taxanos.  Aproximadamente el 80% de estos pacientes son tratados con hormonas de última generación.

 

Citas

Berthold DR, Pond GR, Soban F, de Wit R, Eisenberger M, Tannock IF. Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study. JCO. 2008;26(2):242–5. doi: 10.1200/JCO.2007.12.4008

European Association of Urology. EAU Guidelines Office Rapid Reaction Group: An organisation-wide collaborative effort to adapt the EAU guidelines recommendations to the COVID era. European Association of Urology. Available from: https://uroweb.org/guideline/covid-19-recommendations/?type=appendices-publications,

Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer. Am J Clin Pathol. 2012;137(4):516–42. doi: 10.1309/AJCPTGD94EVRSJCG

Parker C, Nilsson S, Heinrich D, Helle SI, O’Sullivan JM, Fosså SD, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013 Jul 18;369(3):213–23. doi: 10.1056/NEJMoa1213755

Abou DS, Ulmert D, Doucet M, Hobbs RF, Riddle RC, Thorek DLJ. Whole-Body and Microenvironmental Localization of Radium-223 in Naïve and Mouse Models of Prostate Cancer Metastasis. J Natl Cancer Inst. 2015;108(5). doi: 10.1093/jnci/djv380

Publicado
2020-06-01
Sección
Cartas al editor